Treatment Strategies and Risk of Recurrence in Patients With Heart Valve Prosthesis, Staphylococcus aureus Bacteremia, and Possible Endocarditis—A Retrospective Cohort Study | Zendy

Nikita Toth | Zendy; Bo Nilson | Zendy; Andreas Berge | Zendy; Magnus Rasmussen | Zendy

Open Access

Treatment Strategies and Risk of Recurrence in Patients With Heart Valve Prosthesis, Staphylococcus aureus Bacteremia, and Possible Endocarditis—A Retrospective Cohort Study

Author(s) -

Nikita Toth,

Bo Nilson,

Andreas Berge,

Magnus Rasmussen

Publication year - 2022

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofac207

Subject(s) - medicine , endocarditis , bacteremia , retrospective cohort study , staphylococcus aureus , prosthesis , cohort , infective endocarditis , surgery , cohort study , antibiotics , microbiology and biotechnology , bacteria , genetics , biology

Patients with heart valve prosthesis (HVP) and Staphylococcus aureus bacteraemia (SAB) risk endocarditis. In this retrospective, populations-based, cohort study of 134 patients with SAB and HVP, 97 (72%) were diagnosed with possible endocarditis. Despite that most patients with possible endocarditis received short antibiotic treatment, only three patients suffered recurrent SAB.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research